Nibib biomedical device entrepreneurial training
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00345
- Awardee
-
Biocomx UEI FHLJUBQ8YAL7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $724,747
Award facts
- Opportunity
-
- Biomedical Medical Device Commercialization Entrep Solicitation · 75N92021Q0240 · Posted Sep 15, 2021
- Contract value 100% obligated
- $724,747.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 611430 Professional and Management Development Training
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- MONARCH BAY, CA 92629, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,752 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $727,499 |
About this award
The National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, awarded a $724,747 firm fixed-price purchase order to Biocomx for biomedical device entrepreneurial training. The contract, awarded on September 29, 2021 with a completion date of September 28, 2022, was not issued under any set-aside designation. Performance will occur in Monarch Bay, California. This award fulfills a solicitation posted September 15, 2021, which sought a contractor to provide training and support to entrepreneurs and small businesses in advancing the development and commercialization of innovative medical technologies, with virtual training intended to serve up to 50 participants over a one-year period.
Biocomx, which specializes in training and support for early-stage biomedical project teams, is well-positioned to deliver under this requirement given its extensive experience conducting similar entrepreneurial training programs, particularly through its BiocomxC3i Program based on the Coulter Commercialization Process. The contractor's prior federal award history includes significant work with NIH agencies in biomedical technology training and assessment, including over $20 million in contract awards from the NHLBI to support the National Institute of Biomedical Imaging and Bioengineering's COVID-19 RADx initiative. The training provided under this contract will focus on helping participants establish new companies and transition technologies toward commercialization and clinical use.
Quick answers
Who was awarded contract 75N92021P00345?
75N92021P00345 was awarded to Biocomx by National Heart Lung and Blood Institute (National Institutes of Health) on September 29, 2021.
How much is contract 75N92021P00345 worth?
The government has obligated $724,747 on 75N92021P00345.
Was contract 75N92021P00345 competed?
The extent of competition for 75N92021P00345 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award